相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
Shiyang Shen et al.
NATURE NANOTECHNOLOGY (2021)
Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer
Xumin Zhou et al.
PHARMACOLOGICAL RESEARCH (2021)
Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor a and the EGFR/HER2 signaling pathway
Yun-Suk Kwon et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Yiran Liang et al.
SEMINARS IN CANCER BIOLOGY (2020)
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
Francis W. Hunter et al.
BRITISH JOURNAL OF CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements
Sanaz Derech-Haim et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma
Hongxia Dan et al.
MOLECULAR ONCOLOGY (2020)
Whipworm and roundworm infections
Kathryn J. Else et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Breast cancer: Biology, biomarkers, and treatments
Khadijeh Barzaman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers
Yanyuan Wu et al.
CANCERS (2020)
Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study
Kanan Dave et al.
SCIENTIFIC REPORTS (2020)
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
Emilien Loeuillard et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole
K. Rudolf et al.
TOXICOLOGY IN VITRO (2020)
The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
Deok-Soo Son et al.
IMMUNE NETWORK (2020)
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer
Yongqi Zhen et al.
THERANOSTICS (2020)
Treatment of Advanced Prostate Cancer
Min Yuen Teo et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
The evolving role of diet in prostate cancer risk and progression
Adeel Kaiser et al.
CURRENT OPINION IN ONCOLOGY (2019)
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation
Yue Li et al.
CANCER LETTERS (2019)
Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug Interactions
Vladimir Kubicek et al.
FRONTIERS IN PHARMACOLOGY (2019)
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
Shichong Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
ACLY facilitates colon cancer cell metastasis by CTNNB1
Jun Wen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Surgical Treatment of Lung Cancer
Haley Hoy et al.
CRITICAL CARE NURSING CLINICS OF NORTH AMERICA (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The anthelmintic drug flubendazole induces cell apoptosis and inhibits NF-κB signaling in esophageal squamous cell carcinoma
Jiali Tao et al.
ONCOTARGETS AND THERAPY (2019)
Flubendazole as a macrofilaricide: History and background
Timothy G. Geary et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review
Claire H. Li et al.
BREAST CANCER RESEARCH (2019)
Understanding p53 functions through p53 antibodies
Kanaga Sabapathy et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Current treatment strategies for advanced prostate cancer
Kazumasa Komura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2018)
Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer
Jian-Feng Liu et al.
MOLECULAR CARCINOGENESIS (2018)
Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer
Yoon-Jae Kim et al.
CANCER LETTERS (2018)
The metabolism of flubendazole in human liver and cancer cell lines
Lucie Raisova Stuchlikova et al.
DRUG TESTING AND ANALYSIS (2018)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
Eunhye Oh et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells
K. Canova et al.
TOXICOLOGY IN VITRO (2018)
Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines
Vera Kralova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Breast cancer stem cells: Features, key drivers and treatment options
Juergen Dittmer
SEMINARS IN CANCER BIOLOGY (2018)
Adjuvant therapy for resected high-risk melanoma
Justin C. Moser et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2018)
The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells
Veronika Hanusova et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Benzimidazole resistance in helminths: From problem to diagnosis
Luis Fernando et al.
ACTA TROPICA (2016)
Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Snehlata Yadav et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
Vera Kralova et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Potential Anti-cancer Drugs Commonly Used for Other Indications
Veronika Hanusova et al.
CURRENT CANCER DRUG TARGETS (2015)
Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer
Lan Zhang et al.
MOLECULAR BIOSYSTEMS (2015)
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
Sven Perner et al.
ONCOTARGET (2015)
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Zhi-Jie Hou et al.
ONCOTARGET (2015)
Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen
Martin Michaelis et al.
SCIENTIFIC REPORTS (2015)
Cutaneous Malignant Melanoma: Update on Diagnostic and Prognostic Biomarkers
Ossama Abbas et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2014)
Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells
Hong Xie et al.
BMB REPORTS (2014)
Treatment of HER2-positive breast cancer
Maria Cristina Figueroa-Magalhaes et al.
BREAST (2014)
A review of clinical aspects of breast cancer
Shai Libson et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2014)
Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications
F. Montemurro et al.
ANNALS OF ONCOLOGY (2013)
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines
Vera Kralova et al.
ANTI-CANCER DRUGS (2013)
Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo
Ying Chang et al.
CANCER LETTERS (2013)
Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2-Overexpressing Metastatic Breast Cancer
Yuan Huang et al.
CURRENT DRUG TARGETS (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Comparative Performances of Flubendazole and Albendazole in Cystic Echinococcosis: Ex Vivo Activity, Plasma/Cyst Disposition, and Efficacy in Infected Mice
Laura Ceballos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs
Charles D. Mackenzie et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Prostate Cancer
Scott Eggener
THESCIENTIFICWORLDJOURNAL (2011)
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
Paul A. Spagnuolo et al.
BLOOD (2010)
Triple-Negative Breast Cancer Role of Specific Chemotherapy Agents
Steven J. Isakoff
CANCER JOURNAL (2010)
Triple-negative breast cancer: correlation between imaging and pathological findings
Eun Sook Ko et al.
EUROPEAN RADIOLOGY (2010)
Microtubule dynamics as a target in oncology
April L. Risinger et al.
CANCER TREATMENT REVIEWS (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1
Marni Brisson Tierno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to Therapy
Nikolas K. Haass et al.
MOLECULAR DIAGNOSIS & THERAPY (2009)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Flubendazole interferes with a wide spectrum of cell homeostatic mechanisms in Echinococcus granulosus protoscoleces
Andrea C. Cumino et al.
PARASITOLOGY INTERNATIONAL (2009)
Flubendazole in cystic echinococcosis therapy: Pharmaco-parasitological evaluation in mice
Laura Ceballos et al.
PARASITOLOGY INTERNATIONAL (2009)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis
Lan Wang et al.
APOPTOSIS (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
System for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions
T. S. Wehrman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Post-translational modifications regulate microtubule function
S Westermann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Multiple lethal effects induced by a benzimidazole anthelmintic in the anterior intestine of the nematode Haemonchus contortus
DP Jasmer et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
分享论文
